NCT05639816

Brief Summary

Retained CBD stone after ERCP is a common problem in clinical practice. This study aimed to evaluate the effect of saline irrigation of common bile duct after complete stone removal considered by ERCP in the reduction of residual CBD stone and the effect on clinical outcome.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
70

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jan 2021

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2021

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2021

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

March 22, 2022

Completed
9 months until next milestone

First Posted

Study publicly available on registry

December 6, 2022

Completed
Last Updated

December 6, 2022

Status Verified

November 1, 2022

Enrollment Period

12 months

First QC Date

March 22, 2022

Last Update Submit

November 28, 2022

Conditions

Keywords

endoscopic retrograde cholangiopancreatographyendoscopic ultrasoundcholangitis

Outcome Measures

Primary Outcomes (1)

  • prevalence of residual CBD stone

    Detected residual CBD stone by endoscoic ultrasound

    1 day

Secondary Outcomes (2)

  • factors associated with retained CBD stone

    1 day

  • Complicaion and clinical outcome

    6 months

Study Arms (2)

saline irrigation group

EXPERIMENTAL

The patients received saline irrigation of common bile duct after complete ERCP stone removal confirmed by occluded cholangiogram

Procedure: Saline irrigation group

control

NO INTERVENTION

The patients whom complete ERCP stone removal confirmed by occluded cholangiogram were follow up according to standard treatment

Interventions

Normal saline irrigation of common bile duct after complete stone removal

saline irrigation group

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients with common bile duct stone
  • Complete stone removal by endoscopy as seen in occluded cholangiogram

You may not qualify if:

  • unstable vital sign
  • failed complete stone remval
  • assciated biliary malignancy or history of bile duct surgery
  • associated bile duct stricture or choledochal cyst
  • Toxic cholangitis
  • pregnancy or unable to give informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Rajavithi Hospital

Bangkok, Thailand

Location

Related Publications (2)

  • Ang TL, Teo EK, Fock KM, Lyn Tan JY. Are there roles for intraductal US and saline solution irrigation in ensuring complete clearance of common bile duct stones? Gastrointest Endosc. 2009 Jun;69(7):1276-81. doi: 10.1016/j.gie.2008.10.018. Epub 2009 Feb 26.

  • Ahn DW, Lee SH, Paik WH, Song BJ, Park JM, Kim J, Jeong JB, Hwang JH, Ryu JK, Kim YT. Effects of Saline Irrigation of the Bile Duct to Reduce the Rate of Residual Common Bile Duct Stones: A Multicenter, Prospective, Randomized Study. Am J Gastroenterol. 2018 Apr;113(4):548-555. doi: 10.1038/ajg.2018.21. Epub 2018 Mar 27.

MeSH Terms

Conditions

GallstonesCholangitis

Condition Hierarchy (Ancestors)

CholelithiasisBiliary Tract DiseasesDigestive System DiseasesCholecystolithiasisGallbladder DiseasesCalculiPathological Conditions, AnatomicalPathological Conditions, Signs and SymptomsBile Duct Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
The patients are blinded to the treatment
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Included patients are randomized to two group, study group and control group an followed up parallelly.
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 22, 2022

First Posted

December 6, 2022

Study Start

January 1, 2021

Primary Completion

December 31, 2021

Study Completion

December 31, 2021

Last Updated

December 6, 2022

Record last verified: 2022-11

Data Sharing

IPD Sharing
Will not share

Locations